News

  We are very pleased to announce that Carolina Faune will be joining the sales and marketing team in Previwo as Director of Market Development. Based in Bergen, Norway, Carolina will be leading Previwo’s expansion to new markets as well as work to strengthen our cooperation with customers and key stakeholders in Norway and other existing markets.Carolina is a veterinarian with an MBA from Universidad Austral de Chile and brings more than 20 years of experience working in the aquaculture industry. Before joining Previwo, Carolina held the position of Global Market Development Leader in Benchmark Animal Health. Carolina has a ...

We are happy and welcome Anne Bakke Fylling to Previwo. Anne joined on 1 August as a Technical Manager. She will expand our capacity for customer follow-up and will assist in customer verification surveys and implementations with Stembiont. Together with Ragnhild, this makes a strong team. Anne will also use her strong background and training in fish health and immunology to strengthen our research and development team with microbial enhancement products and vaccines. Anne was born and raised on a farm outside Måløy in Nordfjord  with the sea as her nearest neighbour, fish and fishing have naturally been a large ...

Technical Manager Previwo AS Would you like to be an innovator in fish health pioneering a game changing approach in health management? Previwo AS, is a Norwegian based bio-technology company with biological health products for aquaculture that aim to add high value through managing microbial systems for better health, yield, welfare and sustainability. In 2020, the largely research and development-based company entered the commercial phase of company growth.  Since the first microbial enhancement product launch, the adoption of this health measure has been used by over 20 companies.  The company also has a strong pipeline of patent-protected science and technology ...

Vi investerer 12 millioner i økt produksjonskapasitet Vi øker produksjonskapasiteten og investerer 12 millioner kroner i nytt fermenteringssystem For å sikre leveranser, spesielt i høysesong og med den generelle etterspørselsveksten vi opplever investerer vi nå 12 millioner kroner i nytt produksjonsutstyr. Vi har nå kapasitet til å produsere 1200 liter Stembiont per uke. Med det nye fermenterings-systemet ferdig installert nesten tredobler vi nå kapasiteten til 3500 liter per uke. Avtalen er inngått med Belach Bioteknik AB, og det nye fermenteringssystemet er planlagt ferdig installert og i drift i produksjonslokalene våre i løpet av 3. kvartal 2022. Stembiont er ikke hyllevare ...